Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine
Epstein−Barr virus (EBV), a member of the <i>Herpesviridae</i> family, maintains a lifelong latent infection in human B cells. Switching from the latent to the lytic phase of its lifecycle allows the virus to replicate and spread. The viral lytic cycle is induced in infected cu...
Główni autorzy: | Abbie G. Anderson, Cullen B. Gaffy, Joshua R. Weseli, Kelly L. Gorres |
---|---|
Format: | Artykuł |
Język: | English |
Wydane: |
MDPI AG
2019-05-01
|
Seria: | Viruses |
Hasła przedmiotowe: | |
Dostęp online: | https://www.mdpi.com/1999-4915/11/5/450 |
Podobne zapisy
-
Viral and host factors drive a type 1 Epstein–Barr virus spontaneous lytic phenotype
od: Katherine A. Willard, i wsp.
Wydane: (2023-12-01) -
Relationship between Epstein-Barr virus and cancer development
od: Medina-Ortega, Ángela Patricia, i wsp.
Wydane: (2017-04-01) -
Immune Modulation by Epstein–Barr Virus Lytic Cycle: Relevance and Implication in Oncogenesis
od: Nevena Todorović, i wsp.
Wydane: (2024-10-01) -
Editorial: Epstein-Barr virus and its contribution to pediatric tumors
od: Paola Chabay, i wsp.
Wydane: (2022-09-01) -
Epstein-Barr virus reactivation in critically ill immunocompetent patients
od: Nicolas Libert, i wsp.
Wydane: (2015-02-01)